These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9804512)

  • 41. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
    Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful bridge to transplant in a highly sensitized patient with a complicated pump pocket infection.
    McGee EC; Cotts W; Tambur AR; Friedewald J; Kim J; O'Connell J; Wallace S; McCarthy PM
    J Heart Lung Transplant; 2008 May; 27(5):568-71. PubMed ID: 18442726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure.
    Frazier OH; Myers TJ; Westaby S; Gregoric ID
    Ann Surg; 2003 May; 237(5):631-6; discussion 636-7. PubMed ID: 12724629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.
    Frazier OH; Rose EA; Oz MC; Dembitsky W; McCarthy P; Radovancevic B; Poirier VL; Dasse KA;
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1186-95. PubMed ID: 11726895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
    Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
    Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolated left ventricular assist as bridge to cardiac transplantation.
    Starnes VA; Oyer PE; Portner PM; Ramasamy N; Miller PJ; Stinson EB; Baldwin JC; Ream AK; Wyner J; Shumway NE
    J Thorac Cardiovasc Surg; 1988 Jul; 96(1):62-71. PubMed ID: 3290589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation.
    Lavee J; Kormos RL; Duquesnoy RJ; Zerbe TR; Armitage JM; Vanek M; Hardesty RL; Griffith BP
    J Heart Lung Transplant; 1991; 10(6):921-9; discussion 929-30. PubMed ID: 1756157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation.
    O'Connor MJ; Menteer J; Chrisant MR; Monos D; Lind C; Levine S; Gaynor JW; Hanna BD; Paridon SM; Ravishankar C; Kaufman BD
    J Heart Lung Transplant; 2010 Jan; 29(1):109-16. PubMed ID: 20123248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumatic pulsatile ventricular assist device as a bridge to heart transplantation in pediatric patients.
    Amodeo A; Brancaccio G; Michielon G; Filippelli S; Ricci Z; Morelli S; Gagliardi MG; Iacobelli R; Pongiglione G; Di Donato RM
    Artif Organs; 2010 Nov; 34(11):1017-22. PubMed ID: 21092045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement.
    Loebe M; Hennig E; Müller J; Spiegelsberger S; Weng Y; Hetzer R
    Eur J Cardiothorac Surg; 1997 Apr; 11 Suppl():S18-24. PubMed ID: 9271176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.
    Fernández FG; Jaramillo A; Ewald G; Rogers J; Pasque MK; Mohanakumar T; Moazami N
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S255-61. PubMed ID: 15993782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries.
    Michel E; Orozco Hernandez E; Enter D; Monge M; Nakano J; Rich J; Anderson A; Backer C; McCarthy P; Pham D
    Artif Organs; 2019 Jan; 43(1):90-96. PubMed ID: 30129258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression.
    Deng MC; Erren M; Tjan TD; Tamminga N; Werntze B; Zimmermann P; Weyand M; Hammel D; Schmidt C; Scheld HH
    Thorac Cardiovasc Surg; 1999 Feb; 47 Suppl 2():326-31. PubMed ID: 10218610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study.
    El-Banayosy A; Deng M; Loisance DY; Vetter H; Gronda E; Loebe M; Vigano M
    Eur J Cardiothorac Surg; 1999 Jun; 15(6):835-41. PubMed ID: 10431867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices.
    Gonzalez-Stawinski GV; Cook DJ; Chang AS; Atik F; Navia JL; Banbury M; Roselli E; Young JB; Starling RA; Smedira NG
    Transplantation; 2005 May; 79(9):1175-9. PubMed ID: 15880065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biventricular assist devices as a bridge to heart transplantation in small children.
    Gandhi SK; Huddleston CB; Balzer DT; Epstein DJ; Boschert TA; Canter CE
    Circulation; 2008 Sep; 118(14 Suppl):S89-93. PubMed ID: 18824776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.